ARCHIVES

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

NTP Board Considers Modification Of Human Risk Statement, Adopts Plan For Chemical Selection

November 7, 1980

St. Jude Considers Relocating to Washington U.

August 9, 1985

AACR Campaigns For Doubling Funding for Cancer Research In Three Years

April 25, 1997

Organ Systems Extension to CNS, Aerodigestive Tract Considered

July 26, 1985

In Brief: NCAB Objects To Low Priority For Several Cancer Control Grants, Asks For New Review

June 22, 1979

Blacks, Whites Have Same Contralateral Breast Cancer Risk While On Tamoxifen

December 31, 2004